Warlingham, United Kingdom

Mathew L S Leigh

This inventor holds 1 USPTO granted patent. Top assignee: Phares Pharmaceutical Research, N.v.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mathew L S Leigh. Retrieved from https://idiyas.com/inventor/mathew-l-s-leigh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mathew L S Leigh: Innovator in Pharmaceutical Compositions

Introduction

Mathew L S Leigh is a notable inventor based in Warlingham, GB. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compositions for delivering biologically active compounds.

Latest Patents

Mathew holds a patent for "Pharmaceutical compositions and their use." This invention provides a composition designed to deliver at least one biologically active compound to a living organism. The composition comprises at least one micelle-forming membrane lipid, showcasing his innovative approach to drug delivery systems. He has 1 patent to his name.

Career Highlights

Mathew is associated with Phares Pharmaceutical Research N.V., where he applies his expertise in pharmaceutical sciences. His work focuses on advancing drug delivery technologies, which are crucial for improving therapeutic outcomes.

Collaborations

Mathew collaborates with his coworker, Steven Leigh, contributing to the innovative environment at Phares Pharmaceutical Research N.V. Their combined efforts aim to enhance the efficacy of pharmaceutical compositions.

Conclusion

Mathew L S Leigh is a dedicated inventor whose work in pharmaceutical compositions has the potential to impact the field significantly. His innovative contributions continue to pave the way for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…